Welfare-optimal patent royalties when imitation is costly

被引:5
作者
Bertran, Fernando J. Leiva [1 ]
Turner, John L. [2 ]
机构
[1] Arizona State Univ, Dept Econ, Main Campus,POB 873806, Tempe, AZ 85287 USA
[2] Univ Georgia, Dept Econ, Brooks Hall,5th Floor, Athens, GA 30602 USA
关键词
Damages; Entry; Invention; Patents; Prize system; Royalties; INNOVATION; PROTECTION; PRICE;
D O I
10.1016/j.jebo.2017.03.014
中图分类号
F [经济];
学科分类号
02 ;
摘要
We identify welfare-optimal patent royalties in a model of costly imitation, entry and imperfect competition. When the social planner may impose a compulsory license, optimal royalties either blockade imitation, facilitating unregulated monopoly, or yield an aggregate-zero-profit efficient duopoly. When duopoly is optimal, the optimal per-unit royalty pins the equilibrium price at the aggregate average cost and the optimal fixed royalty shifts surplus so the patentee and imitator break even. Efficient duopoly yields higher welfare than monopoly for sufficiently low invention cost, and may also yield higher welfare than a prize system. Interestingly, royalty payments may be negative. Because of this, efficient duopoly may not be feasible if the planner must instead direct the courts to use such royalties. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:457 / 475
页数:19
相关论文
共 30 条
[1]  
[Anonymous], 2008, INTELLECTUAL MONOPOL
[2]  
[Anonymous], 1962, CAPITALISM SOCIALISM
[3]   Finding "lost" profits: An equilibrium analysis of patent infringement damages [J].
Anton, James J. ;
Yao, Dennis A. .
JOURNAL OF LAW ECONOMICS & ORGANIZATION, 2007, 23 (01) :186-207
[4]  
Bain Joe S., 1956, Barriers to New Competition: Their Character and Consequences in Manufacturing
[5]  
Chen T., 2016, WORKING PAPER
[6]   Price and variety in the spokes model [J].
Chen, Yongmin ;
Riordan, Michael H. .
ECONOMIC JOURNAL, 2007, 117 (522) :897-921
[7]   Alternative damage rules and probabilistic intellectual property rights: Unjust enrichment, lost profits, and reasonable royalty remedies [J].
Choi, Jay Pil .
INFORMATION ECONOMICS AND POLICY, 2009, 21 (02) :145-157
[8]  
Coolley Ronald, 1993, J PAT TRADEMARK OFF, V75, P515
[9]   The price of innovation: new estimates of drug development costs [J].
DiMasi, JA ;
Hansen, RW ;
Grabowski, HG .
JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) :151-185
[10]   PATENT POLICY AND COSTLY IMITATION [J].
GALLINI, NT .
RAND JOURNAL OF ECONOMICS, 1992, 23 (01) :52-63